Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This multicenter study examined the impact of albumin excretion rate (AER) on the course of estimated glomerular filtration rate (eGFR) and the incidence of sustained eGFR <60 ml/min/1.73 m2 in type 1 diabetes up to year 14 of the Epidemiology of Diabetes Interventions and Complications (EDIC) study (mean duration of 19 years in the Diabetes Control and Complications Trial [DCCT]/EDIC). RESEARCH DESIGN AND METHODS: Urinary albumin measurements from 4-h urine collections were obtained from participants annually during the DCCT and every other year during the EDIC study, and serum creatinine was measured annually in both the DCCT and EDIC study. GFR was estimated from serum creatinine using the abbreviated Modification of Diet in Renal Disease equation. RESULTS: A total of 89 of 1,439 subjects developed an eGFR <60 ml/min/1.73 m2 (stage 3 chronic kidney disease on two or more successive occasions (sustained) during the DCCT/EDIC study (cumulative incidence 11.4%). Of these, 20 (24%) had AER <30 mg/24 h at all prior evaluations, 14 (16%) had developed microalbuminuria (AER 30–300 mg/24 h) before they reached stage 3 chronic kidney disease, and 54 (61%) had macroalbuminuria (AER >300 mg/24 h) before they reached stage 3 chronic kidney disease. Macroalbuminuria is associated with a markedly increased rate of fall in eGFR (5.7%/year vs. 1.2%/year with AER <30 mg/24 h, P < 0.0001) and risk of eGFR <60 ml/min/1.73 m2 (adjusted hazard ratio 15.3, P < 0.0001), whereas microalbuminuria had weaker and less consistent effects on eGFR. CONCLUSIONS: Macroalbuminuria was a strong predictor of eGFR loss and risk of developing sustained eGFR <60 ml/min/1.73 m2. However, screening with AER alone would have missed 24% of cases of sustained impaired eGFR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced eGFR without albuminuria has been frequently reported in type 1 and type 2 diabetes and is becoming more common over time as the prevalence of diabetes increases in the U.S. (2,3,16,(19)(20)(21).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density Estimation for Statistics and Data Analysis
Silverman, B. W. (2018) · Routledge eBooks · doi:10.1201/9781315140919 · Cited by 15,796
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Self-citationStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Density Estimation for Statistics and Data Analysis
Dehnad, K. (1987) · Technometrics · doi:10.1080/00401706.1987.10488295 · Cited by 5,302
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,384
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., & for the UKPDS Study Group (2006) · Diabetes · doi:10.2337/db05-1620 · Cited by 927
Self-citation
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014
Afkarian, M., Zelnick, L. R., Hall, Y. N., Heagerty, P. J., Tuttle, K., Weiss, N. S., & de Boer, I. H. (2016) · JAMA · doi:10.1001/jama.2016.10924 · Cited by 1,026
Selby, N. M., & Taal, M. W. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14007 · Cited by 764
The Global Epidemiology of Diabetes and Kidney Disease
Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.10.011 · Cited by 686
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes
The DCCT/EDIC Research Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1111732 · Cited by 568
de Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 503
Self-citation11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s011 · Cited by 460
de Ferranti, S. D., de Boer, I. H., Fonseca, V., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 433
Self-citation11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s011 · Cited by 398
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s011 · Cited by 395
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.048 · Cited by 378
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s011 · Cited by 275
Epidemiology of Diabetic Kidney Disease
Reutens, A. T. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.001 · Cited by 326
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s011 · Cited by 344
10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s010 · Cited by 302
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s011 · Cited by 289
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s011 · Cited by 318
Arterial stiffness in diabetes mellitus
Prenner, S. B., & Chirinos, J. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.023 · Cited by 313
Orchard, T. J., Secrest, A. M., Miller, R. G., & Costacou, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1860-3 · Cited by 313
Diabetic Nephropathy and Extracellular Matrix
Kolset, S. O., Reinholt, F. P., & Jenssen, T. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412465073 · Cited by 291
Groop, P.-H., Cooper, M. E., Perkovic, V., Emser, A., Woerle, H.-J., & von Eynatten, M. (2013) · Diabetes Care · doi:10.2337/dc13-0323 · Cited by 294
Krolewski, A. S., Niewczas, M. A., Skupien, J., Gohda, T., Smiles, A., Eckfeldt, J. H., Doria, A., & Warram, J. H. (2014) · Diabetes Care · doi:10.2337/dc13-0985 · Cited by 276
Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis
Tziomalos, K., & Athyros, V. G. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.110 · Cited by 268
The Epidemiology of Diabetic Kidney Disease
Hoogeveen, E. K. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2030038 · Cited by 234
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Molitch, M. E., Adler, A. I., Flyvbjerg, A., Nelson, R. G., So, W.-Y., Wanner, C., Kasiske, B. L., Wheeler, D. C., de Zeeuw, D., & Mogensen, C. E. (2015) · Kidney International · doi:10.1038/ki.2014.128 · Cited by 268
Self-citationde Boer, I. H., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2113 · Cited by 254
“9%) in subjects with microalbuminuria (20).”
Epidemiology of Diabetic Nephropathy
Reutens, A. T., & Atkins, R. C. (2011) · Contributions to Nephrology · doi:10.1159/000324934 · Cited by 235
Ekinci, E. I., Jerums, G., Skene, A., Crammer, P., Power, D., Cheong, K. Y., Panagiotopoulos, S., McNeil, K., Baker, S. T., Fioretto, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2572 · Cited by 223
Clinical predictive factors in diabetic kidney disease progression
Radcliffe, N. J., Seah, J., Clarke, M., MacIsaac, R. J., Jerums, G., & Ekinci, E. I. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12533 · Cited by 208
Thompson, D. M., Meloche, M., Ao, Z., Paty, B., Keown, P., Shapiro, R. J., Ho, S., Worsley, D., Fung, M., Meneilly, G., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31820437f3 · Cited by 213
“We believe that the rate of decline in the medical group is what would be expected from the literature for patients with type 1 diabetes and this degree of proteinuria (2, 9, 10, 16).”
BackgroundDiabetic kidney disease with and without albuminuria
MacIsaac, R. J., & Jerums, G. (2011) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e3283456546 · Cited by 189
Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga
Bakris, G. L., & Molitch, M. (2014) · Diabetes Care · doi:10.2337/dc13-1870 · Cited by 186
Self-citation10. Microvascular Complications and Foot Care
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s013 · Cited by 181
Therapeutic approaches to diabetic nephropathy—beyond the RAS
Fernandez-Fernandez, B., Ortiz, A., Gomez-Guerrero, C., & Egido, J. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.74 · Cited by 170
Vistisen, D., Andersen, G. S., Hulman, A., Persson, F., Rossing, P., & Jørgensen, M. E. (2019) · Diabetes Care · doi:10.2337/dc19-0349 · Cited by 167
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Lo, C., Toyama, T., Wang, Y., Lin, J., Hirakawa, Y., Jun, M., Cass, A., Hawley, C. M., Pilmore, H., Badve, S. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011798.pub2 · Cited by 100
Pugliese, G., Penno, G., Natali, A., Barutta, F., Di Paolo, S., Reboldi, G., Gesualdo, L., & De Nicola, L. (2019) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.07.017 · Cited by 156
Updating the natural history of diabetic nephropathy
Pugliese, G. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0650-7 · Cited by 165
on behalf of the PERL Consortium, Maahs, D. M., Caramori, L., Cherney, D. Z. I., Galecki, A. T., Gao, C., Jalal, D., Perkins, B. A., Pop-Busui, R., Rossing, P., et al. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0381-0 · Cited by 138
9. Microvascular Complications and Foot Care
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s012 · Cited by 172
the Italian Diabetes Society and the Italian Society of Nephrology, Pugliese, G., Penno, G., Natali, A., Barutta, F., Di Paolo, S., Reboldi, G., Gesualdo, L., & De Nicola, L. (2020) · Journal of Nephrology · doi:10.1007/s40620-019-00650-x · Cited by 125
Penno, G., Solini, A., Zoppini, G., Orsi, E., Zerbini, G., Trevisan, R., Gruden, G., Cavalot, F., Laviola, L., Morano, S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0628 · Cited by 134
Self-citationNormoalbuminuric diabetic kidney disease
Chen, C., Wang, C., Hu, C., Han, Y., Zhao, L., Zhu, X., Xiao, L., & Sun, L. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0542-7 · Cited by 131
for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Penno, G., Solini, A., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Lamacchia, O., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4691-2 · Cited by 137
Self-citationObstructive Sleep Apnea and Diabetic Nephropathy
Tahrani, A. A., Ali, A., Raymond, N. T., Begum, S., Dubb, K., Altaf, Q.-A., Piya, M. K., Barnett, A. H., & Stevens, M. J. (2013) · Diabetes Care · doi:10.2337/dc13-0450 · Cited by 126
9. Microvascular Complications and Foot Care
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s012 · Cited by 137
Chronic Kidney Disease in Diabetes
McFarlane, P. A., Cherney, D. Z. I., Gilbert, R. E., & Senior, P. A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.11.004 · Cited by 143
Glucose targets for preventing diabetic kidney disease and its progression
Ruospo, M., Saglimbene, V. M., Palmer, S. C., De Cosmo, S., Pacilli, A., Lamacchia, O., Cignarelli, M., Fioretto, P., Vecchio, M., Craig, J. C., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010137.pub2 · Cited by 111
Bjornstad, P., Cherney, D. Z., Snell-Bergeon, J. K., Pyle, L., Rewers, M., Johnson, R. J., & Maahs, D. M. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv121 · Cited by 111
‘Progressive diabetic nephropathy. How useful is microalbuminuria?: contra’
MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014) · Kidney International · doi:10.1038/ki.2014.98 · Cited by 111
Nonproteinuric diabetic kidney disease
Yamanouchi, M., Furuichi, K., Hoshino, J., Ubara, Y., & Wada, T. (2020) · Clinical and Experimental Nephrology · doi:10.1007/s10157-020-01881-0 · Cited by 108
Panduru, N. M., Forsblom, C. M., Saraheimo, M., Thorn, L. M., Bierhaus, A., Humpert, P. M., Groop, P., & on behalf of the FinnDiane Study Group (2013) · Diabetes Care · doi:10.2337/dc12-1868 · Cited by 106
Nagasu, H., Yano, Y., Kanegae, H., Heerspink, H. J. L., Nangaku, M., Hirakawa, Y., Sugawara, Y., Nakagawa, N., Tani, Y., Wada, J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1081 · Cited by 105
Normoalbuminuric Diabetic Kidney Disease in the U.S. Population
Mottl, A. K., Kwon, K. S., Mauer, M. S., Mayer-Davis, E. J., Hogan, S. L., & Kshirsagar, A. V. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.010 · Cited by 101
Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria
de Boer, I. H., Afkarian, M., Rue, T. C., Cleary, P. A., Lachin, J. M., Molitch, M. E., Steffes, M. W., Sun, W., & Zinman, B. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013091004 · Cited by 100
Self-citationon behalf of the C-STRIDE study group, Yuan, J., Zou, X., Han, S.-P., Cheng, H., Wang, L., Wang, J., Zhang, L., Zhao, M., & Wang, X. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0441-9 · Cited by 106
The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients
Halimi, J. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.04.001 · Cited by 91
Tahrani, A. A., Dubb, K., Raymond, N. T., Begum, S., Altaf, Q. A., Sadiqi, H., Piya, M. K., & Stevens, M. J. (2014) · Diabetologia · doi:10.1007/s00125-014-3211-2 · Cited by 92
Toyama, T., Furuichi, K., Ninomiya, T., Shimizu, M., Hara, A., Iwata, Y., Kaneko, S., & Wada, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071810 · Cited by 87
Microalbuminuria: A parameter that has changed diabetes care
Parving, H., Persson, F., & Rossing, P. R. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.10.014 · Cited by 94
Novel biomarkers for prognosticating diabetic kidney disease progression
Swaminathan, S. M., Rao, I. R., Shenoy, S. V., Prabhu, R., Mohan, P. B., Rangaswamy, D., Bhojaraja, M. V., Nagri, S. K., & Nagaraju, S. P. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03354-7 · Cited by 86
Thorn, L. M., Gordin, D., Harjutsalo, V., Hägg-Holmberg, S., Masar, R., Saraheimo, M., Tolonen, N., Wadén, J., Groop, P., & Forsblom, C. M. (2015) · Diabetes Care · doi:10.2337/dc15-0641 · Cited by 88
The Landscape of Diabetic Kidney Disease in the United States
Duru, O. K., Middleton, T. R., Tewari, M. K., & Norris, K. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0980-x · Cited by 81
Looker, H. C., Mauer, M. S., Saulnier, P., Harder, J. L., Nair, V., Boustany, C., Guarnieri, P., Hill, J., Esplin, C. A., Kretzler, M., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018111166 · Cited by 76
Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes
Kim, S. S., Kim, J. H., & Kim, I. J. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.245 · Cited by 86
Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency
Shimizu, M., Furuichi, K., Yokoyama, H., Toyama, T., Iwata, Y., Sakai, N., Kaneko, S., & Wada, T. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0870-0 · Cited by 77
Perez-Gomez, M., Sanchez-Niño, M., Sanz, A., Martín-Cleary, C., Ruiz-Ortega, M., Egido, J., Navarro-González, J., Ortiz, A., & Fernandez-Fernandez, B. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4061325 · Cited by 68
Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: A prospective study
Verhave, J. C., Bouchard, J., Goupil, R., Pichette, V., Brachemi, S., Madore, F., & Troyanov, S. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.07.006 · Cited by 72
Diabetic kidney disease in children and adolescents
Afkarian, M. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2796-5 · Cited by 71
Implications of Proteinuria: CKD Progression and Cardiovascular Outcomes
Sarnak, M. J., & Astor, B. C. (2011) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2011.04.002 · Cited by 69
Natural History and Clinical Characteristics of CKD in Type 1 and Type 2 Diabetes Mellitus
Marshall, S. M. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.007 · Cited by 69
Pugliese, G., Solini, A., Bonora, E., Fondelli, C., Orsi, E., Nicolucci, A., & Penno, G. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.02.013 · Cited by 74
Screening for liver fibrosis by using FibroScan® and FibroTest in patients with diabetes
de Lédinghen, V., Vergniol, J., Gonzalez, C., Foucher, J., Maury, E., Chemineau, L., Villars, S., Gin, H., & Rigalleau, V. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.12.005 · Cited by 64
Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?
Marshall, S. M. (2012) · Diabetologia · doi:10.1007/s00125-012-2606-1 · Cited by 66
Novel urinary biomarkers in pre-diabetic nephropathy
Garg, V., Kumar, M., Mahapatra, H. S., Chitkara, A., Gadpayle, A. K., & Sekhar, V. (2015) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1085-3 · Cited by 67
Chen, Y., Liu, Q., Shan, Z., Mi, W., Zhao, Y., Li, M., Wang, B., Zheng, X., & Feng, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01477 · Cited by 64
Nangaku, M., Takama, H., Ichikawa, T., Mukai, K., Kojima, M., Suzuki, Y., Watada, H., Wada, T., Ueki, K., Narita, I., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac242 · Cited by 55
Maftei, O., Pena, A. S., Sullivan, T., Jones, T. W., Donaghue, K. C., Cameron, F. J., Davis, E., Cotterill, A., Craig, M. E., Gent, R., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0700 · Cited by 53
Xu, L., Wan, X., Huang, Z., Zeng, F., Wei, G., Fang, D., Deng, W., & Li, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061387 · Cited by 53
Penno, G., Russo, E., Garofolo, M., Daniele, G., Lucchesi, D., Giusti, L., Sancho, V., Bianchi, C., Dardano, A., Miccoli, R., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4251-1 · Cited by 54
Clinical and pathological factors associated with progression of diabetic nephropathy
Liang, S., Cai, G., & Chen, X. (2017) · Nephrology · doi:10.1111/nep.13182 · Cited by 55
Evans, M., Morgan, A. R., Patel, D., Dhatariya, K., Greenwood, S. A., Newland‐Jones, P., Hicks, D., Yousef, Z. R., Moore, J., Kelly, B., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00963-2 · Cited by 57
Curovic, V. R., Theilade, S., Winther, S. A., Tofte, N., Eugen‐Olsen, J., Persson, F., Hansen, T. W., Jeppesen, J., & Rossing, P. R. (2019) · Diabetes Care · doi:10.2337/dc18-1427 · Cited by 53
Zhou, B., Zou, H., & Xu, G. (2016) · Kidney & Blood Pressure Research · doi:10.1159/000452593 · Cited by 51
Lee, Y. H., Kim, K.-P., Kim, Y., Moon, J.-Y., Jung, S. W., Park, E.-J., Kim, J. S., Jeong, K. H., Lee, T. W., Ihm, C., et al. (2017) · Medicine · doi:10.1097/md.0000000000008047 · Cited by 51
Afkarian, M., Polsky, S., Parsa, A., Aronson, R., Caramori, M. L., Cherney, D. Z. I., Crandall, J. P., de Boer, I. H., Elliott, T. G., Galecki, A. T., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0342 · Cited by 50
Self-citationUpdate on Estimation of Kidney Function in Diabetic Kidney Disease
Bjornstad, P., Cherney, D. Z. I., & Maahs, D. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0633-2 · Cited by 52
Yang, Z., Feng, L.-H., Huang, Y., & Xia, N. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s223144 · Cited by 47
Longitudinal Changes in Estimated and Measured GFR in Type 1 Diabetes
de Boer, I. H., Sun, W., Cleary, P. A., Lachin, J. M., Molitch, M. E., Zinman, B., & Steffes, M. W. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050557 · Cited by 46
Self-citationZhan, M., Usman, I., Yu, J., Ruan, L., Bian, X., Yang, J. J., Yang, S., Sun, L., & Kanwar, Y. S. (2018) · Clinical Science · doi:10.1042/cs20180005 · Cited by 48
Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease
Duan, S., Fang, L., Song, D., Zhang, C., Zhang, B., Xing, C., & Yuan, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.661185 · Cited by 50
Sinclair, A. J., Dunning, T. L., Dhatariya, K., & an International Group of Experts (2019) · Diabetic Medicine · doi:10.1111/dme.14135 · Cited by 44
Present and Future in the Treatment of Diabetic Kidney Disease
Quiroga, B., Arroyo, D., & de Arriba, G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/801348 · Cited by 40
Pacilli, A., Viazzi, F. C., Fioretto, P., Giorda, C. B., Ceriello, A., Genovese, S., Russo, G. T., Guida, P., Pontremoli, R., Cosmo, S. D., et al. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2873 · Cited by 44
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis
Comai, G., Malvi, D., Angeletti, A., Vasuri, F., Valente, S., Ambrosi, F., Capelli, I., Ravaioli, M., Pasquinelli, G., D’Errico, A., et al. (2019) · American Journal of Nephrology · doi:10.1159/000500353 · Cited by 40
Farmer, A. A., Stevens, R., Hirst, J. A., Lung, T. W.-C., Oke, J. L., Clarke, P., Glasziou, P., Neil, A., Dunger, D. B., Colhoun, H. M., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18140 · Cited by 44
Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease
Looker, H. C., Mauer, M. S., & Nelson, R. G. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.11.004 · Cited by 45
Estimation of renal function in patients with diabetes
Rigalleau, V., Beauvieux, M.-C., González, C., Raffaitin, C., Lasseur, C., Combe, C., Chauveau, P., de la Faille, R., Rigothier, C., Barthe, N., et al. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.05.002 · Cited by 39
Progress in Defining the Genetic Basis of Diabetic Complications
Dahlström, E. H., & Sandholm, N. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0906-z · Cited by 38
Metadata
- Authors
- Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group
- Affiliations
- Northwestern University (US)
- University of Minnesota (US)
- George Washington University (US)
- Weststat, Rockville, Maryland;
- University of Washington, Seattle, Washington;
- University of Toronto (CA)
- Corresponding author
- Cleary, Patricia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-04-22
- Volume
- 33
- Issue
- 7
- Pages
- 1536-1543
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890355
- OpenAlex
- W2112283107
- Semantic Scholar
- 28dfcf1a74005b6164f159cf1b64cfec2aecc582
- Cited by
- 306
- References
- 31
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 15 · 2023: 13 · 2022: 25 · 2021: 19 · 2020: 17 · 2019: 25 · 2018: 23 · 2017: 17 · 2016: 17 · 2015: 24 · 2014: 33 · 2013: 23 · 2012: 22
- FWCI
- 15.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- type 1 diabetes, albuminuria, macroalbuminuria, microalbuminuria, urinary albumin excretion rate, chronic kidney disease, estimated glomerular filtration rate decline, renal failure, diabetic nephropathy, Diabetes Control and Complications Trial, kidney disease screening, glycemic control, blood pressure control
- MeSH terms
- Adult, Albuminuria, Creatinine, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Male, Predictive Value of Tests, Risk Factors, Severity of Illness Index, Multicenter Studies as Topic, Incidence, Randomized Controlled Trials as Topic, Disease Progression, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.